Contents
1.Autologous NK cell + allogeneic NK cell exosome combination therapy
Cancer treatment using NK cells is an immunotherapy that increases the attack power against cancer cells by collecting lymphocytes from the patient’s own blood, culturing them using interleukin (IL)-2, etc., expanding NK cells and NKT cells, adding active NK activation functions, and injecting them into the body. This treatment aims to help eliminate cancer cells and can be used in conjunction with conventional chemotherapy and radiation therapy.
At our clinic, in order to further increase the activity of NK cells, we inject exosomes secreted by NK cells intravenously to enhance the antitumor effect. Since it is expected to be more effective than conventional NK cell therapy, we believe it is suitable for patients whose cancer is more advanced and whose immune system is weakened.
The progress of an example is shown below.
2.Cancer DNA repair (reprogramming) treatment
A low-molecular compound called Benthethonium induces microRNA (miR-520d).
miR-520d converts cancer cells into iPS (reprogramming) and transforms them into normal cells. Normalized cells divide repeatedly and eventually undergo apoptosis and disappear.
It is also expected that cancer cells will disappear, and that damaged DNA sequences will be repaired normally and that re-cancer formation will be prevented. This is a cancer treatment based on a new concept developed in the 21st century.
About side effects
Since the concentration of benzethonium chloride in DNA repair treatment is less than 0.02% and betaxolol is less than 0.1%, it is known that no adverse events occur. However, there have been reports of systemic pruritus as a side effect when administering benzethonium chloride.
3.4th generation activated macrophage therapy
4th generation Gc-MAF specifically activates M1 macrophages with antitumor effects. Activating immunosuppressive M2 macrophages suppresses cancer immunity, leading to cancer progression. M2 macrophages were also activated until the third generation.
Activated M1 macrophages phagocytose cancer cells and release TNF (tumor necrosis factor), which induces cancer cells to undergo apoptosis. Since M1 macrophages cause inflammation, side effects such as fever and allergies are a problem, but this 4th generation Gc-MAF is said to activate M1 macrophages to a degree that causes no side effects and exerts antitumor effects.
It has been reported that when used in combination with NK cell therapy, it improves the immune system of cancer patients and suppresses the progression of cancer (see figure below).
費用
NK cell + NK cell exosome therapy
| 1 course of NK cell treatment + NK cell exosome once a week for 11 weeks |
DNA repair reprogramming therapy (metoprolol or betaxolol hydrochloride)
| Contents | Add 3ml of one vial to 50ml of physiological saline and infuse 53ml at a time. |
|---|---|
| Duration | 1 course of 3 months of cancer treatment (administered twice/week) |
Macrophage activation therapy (Gc-MAF therapy)
| Contents | 4th generation Gc-MAF “ImmunoD” (administered twice/week) |
|---|---|
| Duration | Cancer treatment: 1 course of 3 months (administered twice/week) |
Saisei no Mori Clinic Roppongi original cancer immunotherapy set
A set (strongest): NK cells + NK cell exosome therapy + DNA repair reprogramming therapy + 4th generation Gc-MAF therapy + 2 types of supplements (3 month course) + 2 TAQ tests to determine cancer treatment effectiveness
B set: NK cells + NK cell exosome therapy + DNA repair reprogramming therapy + 1 type of supplement (3 month course) + 2 TAQ tests to determine cancer treatment effectiveness
C set: NK cells + NK cell exosome therapy + 1 type of supplement (3 month course) + 2 TAQ tests to determine cancer treatment effectiveness
Shirotosugi extract grains
| Contents | Taxol-containing supplement (expected to be effective in increasing the sensitivity of NK cells and macrophages) |
|---|---|
| Duration | 1 course of cancer treatment for 3 months (3 packets/day, taken in the morning, noon and evening, after meals) |
| Shape | 90 sachets/box (6 tablets/1 sachet) |
alpha2H+
| Contents | Beverage drink containing α-ketoglutaric acid (expected to be effective in promoting the excretion of waste products from cancer cells and aging cells) |
|---|---|
| Duration | Cancer treatment 1 course for 3 months (20ml/day after dinner) | Shape | 200ml/bottle |
*Reservations and advance payments are required for all reagent manufacturing
outsourcing costs and related products.
※A side effect of benzethonium chloride is itching, in which case we will switch to metoprolol or betaxolol hydrochloride.
